• 1
    Myers JE, Baker PN. Hypertensive diseases and eclampsia. Current Opinion in Obstetrics and Gynecology 2002; 14:119125.
  • 2
    National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology 1990; 163:16911712.
  • 3
    Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. Canadian Medical Association Journal 1997; 157:715725.
  • 4
    Hubel C. Oxidative stress in the pathogenesis of preeclampsia. Proceedings of the Society for Experimental Biology and Medicine 1999; 222:222235.
  • 5
    Levine RJ, Karumanchi SA. Circulating angiogenic factors in preeclampsia. Clinical Obstetrics and Gynecology 2005; 48:372386.
  • 6
    Saftlas AF, Beydoun H, Triche E. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstetrics and Gynecology 2005; 106:162172.
  • 7
    Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. British Medical Journal 2005; 330:565.
  • 8
    Badria LF, Amarin ZO. Pre-eclampsia: is it a different disease in primiparous and multiparous women? Archives of Gynecology and Obstetrics 2005; 273:2631.
  • 9
    Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341:14471451.
  • 10
    Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstetrical and Gynecological Survey 1998; 53:377382.
  • 11
    Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, Klebanoff M, et al. Predictors of pre-eclampsia in women at high risk. American Journal of Obstetrics and Gynecology 1998; 179:946951.
  • 12
    Eras JL, Saftlas AF, Triche E, Hsu CD, Risch HA, Bracken MB. Abortion and its effect on risk of preeclampsia and transient hypertension. Epidemiology 2000; 11:3643.
  • 13
    Papageorghiou AT, Yu CKH, Erasmus IE, Cuckle HS, Nicolaides KH. Assessment of risk for the development of preeclampsia by maternal characteristics and uterine artery Doppler. British Journal of Obstetrics and Gynaecology 2005; 112:703709.
  • 14
    Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor for preeclampsia in multiparas. Epidemiology 1996; 7:240244.
  • 15
    Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991; 266:237241.
  • 16
    Dempsey JC, Sorensen TK, Qiu CF, Luthy DA, Williams MA. History of abortion and subsequent risk of preeclampsia. Journal of Reproductive Medicine 2003; 48:509514.
  • 17
    Coonrod DV, Hickok DE, Zhu K, Easterling TR, Daling JR. Risk factors for preeclampsia in twin pregnancies: a population-based cohort study. Obstetrics and Gynecology 1995; 85:645650.
  • 18
    Lee CJ, Hsieh TT, Chiu TH, Chen KC, Lo LM, Hung TH. Risk factors for pre-eclampsia in an Asian population. International Journal of Gynaecology and Obstetrics 2000; 70:327333.
  • 19
    Stone JL, Lockwood CJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowitz RL. Risk factors for severe preeclampsia. Obstetrics and Gynecology 1994; 83:357361.
  • 20
    Harlikainen AL, Aliharmi RH, Rantakallio PT. A cohort study of epidemiological associations and outcomes of pregnancies with hypertensive disorders. Hypertension in Pregnancy 1998; 17:3141.
  • 21
    Chen CL, Cheng Y, Wang PH, Juang CM, Chiu LM, Yang MJ, et al. Review of pre-eclampsia in Taiwan: a multi-institutional study. Zhonghua Yi Xue Za Zhi (Taipei) [Chinese Medical Journal] 2000; 63:869875.
  • 22
    Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? American Journal of Obstetrics and Gynecology 2000; 182:589594.
  • 23
    Basso O, Wilcox AJ, Weinberg CR, Baird DD, Olsen J. Height and risk of severe pre-eclampsia. A study within the Danish National Birth Cohort. International Journal of Epidemiology 2004; 33:858863.
  • 24
    Mittendorf R, Lain KY, Williams MA, Walker CK. Preeclampsia. A nested, case-control study of risk factors and their interactions. Journal of Reproductive Medicine 1996; 41:491496.
  • 25
    Al-Mulhim AA, Abu-Heija A, Al-Jamma F, El-Harith El-HA. Pre-eclampsia: maternal risk factors and perinatal outcome. Fetal Diagnosis and Therapy 2003; 18:275280.
  • 26
    Maxwell CV, Lieberman E, Norton M, Cohen A, Seely EW, Lee-Parritz A. Relationship of twin zygosity and risk of preeclampsia. American Journal of Obstetrics and Gynecology 2001; 185:819821.
  • 27
    Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Risk factors and clinical manifestations of pre-eclampsia. British Journal of Obstetrics and Gynaecology 2000; 107:14101416.
  • 28
    Funai EF, Paltiel OB, Malaspina D, Friedlander Y, Deutsch L, Harlap S. Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem Perinatal Study. Paediatric and Perinatal Epidemiology 2005; 19:5968.
  • 29
    Misra DP, Kiely JL. The association between nulliparity and gestational hypertension. Journal of Clinical Epidemiology 1997; 50:851855.
  • 30
    Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. New England Journal of Medicine 2002; 346:3338.
  • 31
    Irwin DE, Savitz DA, Hertz-Picciotto IH, St Andre KA. The risk of pregnancy-induced hypertension: black and white differences in a military population. American Journal of Public Health 1994; 84:15081510.
  • 32
    Lawoyin TO, Ani F. Epidemiologic aspects of pre-eclampsia in Saudi Arabia. East African Medical Journal 1996; 73:404406.
  • 33
    Zhang J, Christianson RE, Torfs CP. Fetal trisomy 21 and maternal preeclampsia. Epidemiology 2004; 15:195201.
  • 34
    Long PA, Abell DA, Beischer NA. Parity and pre-eclampsia. Australian and New Zealand Journal of Obstetrics and Gynaecology 1979; 19:203206.
  • 35
    Mahomed K, Williams MA, Woelk GB, Jenkins-Woelk L, Mudzamiri S, Madzime S, et al. Risk factors for preeclampsia-eclampsia among Zimbabwean women: recurrence risk and familial tendency towards hypertension. Journal of Obstetrics and Gynecology 1998; 18:218222.
  • 36
    Bobrowski RA, Bottoms SF. Underappreciated risks of the elderly multipara. American Journal of Obstetrics and Gynecology 1995; 172:17641767.
  • 37
    Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clinical and Experimental Immunology 1999; 117:550555.
  • 38
    Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. American Journal of Reproductive Immunology 1999; 41:297306.
  • 39
    Saito S, Sakai M. Th1/Th2 balance in preeclampsia. Journal of Reproductive Immunology 2003; 59:161173.
  • 40
    Mekori YA, Becker M, Moalem I, Schneider A, Bott G, Klajman A. Immunological features of preeclampsia: increased frequency of antilymphocyte antibodies, but not of immune complexes. Israel Journal of Medical Sciences 1981; 17:10511055.
  • 41
    Barden AE, Beilin LJ, Ritchie J, Walters BN, Graham D, Michael CA. Is proteinuric pre-eclampsia a different disease in primigravida and multigravida? Clinical Science (London) 1999; 97:475483.
  • 42
    Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Reproductive immunology 2003: reassessing the Th1/Th2 paradigm? Immunology Letters 2004; 92:207214.
  • 43
    Wolf M, Shah A, Lam C, Martinez A, Smirnakis KV, Epstein FH, et al. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. American Journal of Obstetrics and Gynecology 2005; 193:1622.
  • 44
    Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA 2005; 294:27512757.
  • 45
    Wolf M, Sandler L, Jimenez-Kimble R, Shah A, Ecker JL, Thadhani R. Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension 2002; 40:886891.
  • 46
    Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, Ten Kate LP, Arngrimsson R. Searching for preeclampsia genes: the current position. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2002; 105:94113.
  • 47
    Trogstad L, Skrondal A, Stoltenberg C, Magnus P, Nesheim BI, Eskild A. Recurrence risk of preeclampsia in twin and singleton pregnancies. American Journal of Medical Genetics A 2004; 126:4145.